AMAL Therapeutics Raises €8 Million (CHF 8.8 Million) in First Closing of Series B Financing Round

Uncategorized September 5, 2017 at 1:54 PM 0 comments

Financing round co-led by Boehringer Ingelheim Venture Fund, BioMedPartners and Helsinn Investment Fund Funds will be used to support: Clinical development of lead vaccine (ATP128) for colorectal cancer through to clinical proof-of-concept Further development of KISIMA technology platform for therapeutic tumour vaccination Geneva, Switzerland, 05 September, 2017 – AMAL TherapeuticsRead More

Introducing the European Medical Journal 2.3

Introducing the European Medical Journal 2.3

Uncategorized August 31, 2017 at 8:30 AM 0 comments

United Kingdom, August 31, 2017: Welcome to this year’s third instalment of the European Medical Journal. The issue contains an abundance of high-quality, peer-reviewed articles from a variety of medical fields, including oncology, cardiology, urology, and haematology. Haematologists in particular will not want to miss this edition, as it containsRead More

Philips supports global transformation of pathology with two new fully digitized labs in Austria

Uncategorized August 30, 2017 at 11:45 AM 0 comments

With availability for primary diagnostic use in North America, Europe and Asia, Philips IntelliSite Pathology Solution is helping labs worldwide to improve the efficiency and quality of cancer diagnostics. Amsterdam, 29 August, 2017 – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the continued momentum of its cutting-edgeRead More

Study Results: Titanium-Nitride-Oxide (TiNO) Coated Stent Is Non-Inferior to Bioabsorbable Polymer Everolimus-Eluting Stent (EES), for Patients Presenting with Acute Coronary Syndrome (ACS)

Uncategorized August 30, 2017 at 11:42 AM 0 comments

Barcelona, 29 August, 2017 – During the Late Breaking Science session at the European Society of Cardiology (ESC) Congress in Barcelona, Dr. Pim Tonino (interventional cardiologist, Heart center Catharina Hospital, Eindhoven, the Netherlands) presented study results comparing TiNO coated stents (OPTIMAXTM from Hexacath, Paris, France) versus EES (SYNERGYTM from BostonRead More

Immatics Initiates Personalized Adoptive Cellular Therapy in Patients with Relapsed And/Or Refractory Solid Cancers Using Its Pioneering Target Warehouse

Oncology August 24, 2017 at 10:30 AM 0 comments

Houston, Texas, USA and Tuebingen, Germany, 21 August, 2017 – Immatics, a leading company in the field of cancer immunotherapy, today announced that it has initiated enrolment of patients into a phase I trial of its first adoptive cellular therapy (ACT) IMA101, using its proprietary ACTolog® approach. The IMA101 phaseRead More

Orchard Therapeutics Announces That OTL-101 Has Received a Designation as Promising Innovative Medicine by UK’s Regulatory Agency

Uncategorized August 24, 2017 at 10:27 AM 0 comments

London, UK, 22 August, 2017 – Orchard Therapeutics Limited (“Orchard”), a clinical-stage biotechnology company developing transformative gene therapies for patients with severe inherited orphan diseases, today announces that the UK Medicines and Healthcare Products Regulatory Agency (“MHRA”) granted a Promising Innovative Medicine Designation to OTL-101, its lead programme for theRead More

Introducing EMJ Reproductive Health 3.1

Introducing EMJ Reproductive Health 3.1

Reproductive Health August 17, 2017 at 8:57 AM 0 comments

United Kingdom, August 17, 2017: A warm welcome to the 2017 EMJ Reproductive Health eJournal! This instalment gives a complete review of the much-anticipated European Society of Human Reproduction and Embryology (ESHRE) congress, this year held in Geneva, Switzerland, from 2nd–5th July. Subjects discussed there spanned ovarian rejuvenation, germline geneRead More

The University of Huddersfield’s Pressure Ulcer Experts Team up Bruin Biometrics Based in Los Angeles

The University of Huddersfield’s Pressure Ulcer Experts Team up Bruin Biometrics Based in Los Angeles

Innovations August 11, 2017 at 11:33 AM 0 comments

The strategic alliance will focus on the use of the SEM scanner early detection technology to attack the UK’s £2 billion+ health problem 9 August, 2017 – An innovative research collaboration between the University of Huddersfield and the Los Angeles-based medical device company Bruin Biometrics (BBI, LLC) has been revealed. ExpertsRead More

Helsinn Group and MEI Pharma Announce First Patient Dosed in Pivotal Phase 3 Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia

Hematology, Oncology August 3, 2017 at 1:54 PM 0 comments

Randomized, double-blind, placebo-controlled study to enroll up to 500 patients worldwide Lugano, Switzerland and San Diego, USA, 2 August, 2017 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapiesRead More

Introducing EMJ Allergy & Immunology 2.1

Introducing EMJ Allergy & Immunology 2.1

Allergy & Immunology August 3, 2017 at 8:45 AM 0 comments

United Kingdom, August 03, 2017: EMJ would like to welcome you to the latest edition of EMJ Allergy and Immunology. This much-anticipated eJournal contains a comprehensive summary of the 61st Annual Meeting of the European Academy of Allergy and Clinical Immunology Congress (EACCI), as well as a selection of outstandingRead More